Joshua Sharp

Practice Areas

Government Investigations & White Collar Defense

State Attorneys General

Litigation

False Claims Act & Qui Tam Matters

Life Sciences & Healthcare Compliance and Investigations

Foreign Corrupt Practices Act (FCPA)

Israel

Complex Disputes

Financial Institution Investigations

Appellate

Professional Memberships

American Bar Association

Boston Bar Association

Boston’s Future Leaders, Greater Boston Chamber of Commerce (2019)

Career

Josh Sharp is a nationally recognized litigator. He represents corporations and individuals in government investigations, regulatory inquiries, and complex civil and criminal litigation. Josh recently secured reversal of his client’s criminal conviction in the first “Varsity Blues” college admissions matter to go to trial. He also recently won dismissal of a $3 billion civil RICO lawsuit filed in the District of Massachusetts.

My focus

I assist clients with internal investigations, regulatory inquiries, grand jury matters, and criminal defense. I also litigate civil matters in state and federal courts.

Financial Institutions Investigations

I represent banks and broker-dealers in investigations by the Department of Justice, the SEC, FinCEN, and FINRA. I have substantial experience with the Bank Secrecy Act and FinCEN’s anti-money laundering regulations.

Health Care, Life Sciences and False Claims Act Litigation

I represent life sciences companies and health care providers in both internal matters and Department of Justice investigations. I have significant experience with the False Claims Act, the Anti-Kickback statute and the Federal Food, Drug, and Cosmetic Act.

Civil Litigation

In addition to my investigations work, I regularly represent clients in state and federal courts in business litigation matters. I recently obtained dismissal with prejudice of a $3 billion RICO lawsuit filed in the District of Massachusetts.

Looking ahead

For many years, whistleblowers have been the driving force behind corporate criminal enforcement, both through the False Claims Act and the Dodd-Frank whistleblower provisions. In January 2021, the Anti-Money Laundering Act of 2020 became law, providing for whistleblower rewards of up to 30% of monetary sanctions imposed for successful Bank Secrecy Act enforcement actions. The enhanced incentives to report anti-money laundering violations are likely to trigger further government scrutiny in this space.

Education